Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 5;5(3):526-537.
doi: 10.1002/hep4.1651. eCollection 2021 Mar.

Early Allograft Dysfunction Increases Hospital Associated Costs After Liver Transplantation-A Propensity Score-Matched Analysis

Affiliations

Early Allograft Dysfunction Increases Hospital Associated Costs After Liver Transplantation-A Propensity Score-Matched Analysis

Simon Moosburner et al. Hepatol Commun. .

Abstract

Concepts to ameliorate the continued mismatch between demand for liver allografts and supply include the acceptance of allografts that meet extended donor criteria (ECD). ECD grafts are generally associated with an increased rate of complications such as early allograft dysfunction (EAD). The costs of liver transplantation for the health care system with respect to specific risk factors remain unclear and are subject to change. We analyzed 317 liver transplant recipients from 2013 to 2018 for outcome after liver transplantation and hospital costs in a German transplant center. In our study period, 1-year survival after transplantation was 80.1% (95% confidence interval: 75.8%-84.6%) and median hospital stay was 33 days (interquartile rage: 24), with mean hospital costs of €115,924 (SD €113,347). There was a positive correlation between costs and laboratory Model for End-Stage Liver Disease score (rs = 0.48, P < 0.001), and the development of EAD increased hospital costs by €26,229. ECD grafts were not associated with a higher risk of EAD in our cohort. When adjusting for recipient-associated risk factors such as laboratory Model for End-Stage Liver Disease score, recipient age, and split liver transplantation with propensity score matching, only EAD and cold ischemia increased total costs. Conclusion: Our data show that EAD leads to significantly higher hospital costs for liver transplantation, which are primarily attributed to recipient health status. Strategies to reduce the incidence of EAD are needed to control costs in liver transplantation.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Costs per liver transplantation. (A) Histogram of total hospital‐associated costs (median and mean costs indicated). (B) Balloon plot of cost per liver transplantation distribution (larger dots equal higher costs). Currency format is EURO (€), which translates approximately to US $1.15 in the third quarter of 2020.
FIG. 2
FIG. 2
Donor criteria and total hospital costs. (A‐I) Donor risk factors and association with total hospital cost. Currency format is EURO (€), which translates approximately to US $1.15 in the third quarter of 2020.
FIG. 3
FIG. 3
Recipient criteria and total hospital costs. (A‐I) Recipient risk factors and association with total hospital cost. Currency format is EURO (€), which translates approximately to US $1.15 in the third quarter of 2020.
FIG. 4
FIG. 4
Donor criteria and total hospital costs after propensity score matching. (A‐I) Donor risk factors and association with total hospital cost after propensity score matching for recipient risk factors. Currency format is EURO (€), which translates approximately to US $1.15 in the third quarter of 2020.

Comment in

References

    1. Orman ES, Mayorga ME, Wheeler SB, Townsley RM, Toro‐Diaz HH, Hayashi PH, et al. Declining liver graft quality threatens the future of liver transplantation in the United States. Liver Transpl 2015;21:1040‐1050. - PMC - PubMed
    1. Toro‐Díaz H, Mayorga ME, Barritt AS, Orman ES, Wheeler SB. Predicting liver transplant capacity using discrete event simulation. Med Decis Making 2015;35:784‐796. - PMC - PubMed
    1. Ishaque T, Massie AB, Bowring MG, Haugen CE, Ruck JM, Halpern SE, et al. Liver transplantation and waitlist mortality for HCC and non‐HCC candidates following the 2015 HCC exception policy change. Am J Transplant 2019;19:564‐572. - PMC - PubMed
    1. Haugen CE, McAdams‐DeMarco M, Holscher CM, Ying H, Gurakar AO, Garonzik‐Wang J, et al. Multicenter study of age, frailty, and waitlist mortality among liver transplant candidates. Ann Surg 2020;271:1132‐1136. - PMC - PubMed
    1. Jackson KR, Motter JD, Haugen CE, Holscher C, Long JJ, Massie AB, et al. Temporal trends in utilization and outcomes of steatotic donor livers in the United States. Am J Transplant 2020;20:855‐863. - PubMed

Publication types